Nathan Treybeck
Stock Analyst at Wells Fargo
(1.36)
# 3,634
Out of 5,245 analysts
30
Total ratings
27.78%
Success rate
-2.29%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Nathan Treybeck
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LMAT LeMaitre Vascular | Maintains: Equal-Weight | $94 → $104 | $97.75 | +6.39% | 4 | May 6, 2026 | |
| IRTC iRhythm Holdings | Maintains: Overweight | $200 → $180 | $116.96 | +53.91% | 8 | May 1, 2026 | |
| RMD ResMed | Maintains: Equal-Weight | $270 → $227 | $208.05 | +9.11% | 3 | May 1, 2026 | |
| PRCT PROCEPT BioRobotics | Maintains: Overweight | $51 → $34 | $29.00 | +17.24% | 10 | Feb 26, 2026 | |
| ITGR Integer Holdings | Maintains: Equal-Weight | $72 → $84 | $89.28 | -5.91% | 5 | Feb 20, 2026 |
LeMaitre Vascular
May 6, 2026
Maintains: Equal-Weight
Price Target: $94 → $104
Current: $97.75
Upside: +6.39%
iRhythm Holdings
May 1, 2026
Maintains: Overweight
Price Target: $200 → $180
Current: $116.96
Upside: +53.91%
ResMed
May 1, 2026
Maintains: Equal-Weight
Price Target: $270 → $227
Current: $208.05
Upside: +9.11%
PROCEPT BioRobotics
Feb 26, 2026
Maintains: Overweight
Price Target: $51 → $34
Current: $29.00
Upside: +17.24%
Integer Holdings
Feb 20, 2026
Maintains: Equal-Weight
Price Target: $72 → $84
Current: $89.28
Upside: -5.91%